Heron Therapeutics | HRTX - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
ALKERMES USD 102.36M 5.59M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amarin USD 48.15M 2.8M 2026-03
ANI Pharmaceuticals USD 69.69M 7.11M 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
Eisai JPY 75.89B 9.6B 2026-03
Emergent BioSolutions USD 112.2M 500K 2023-12
Esperion Therapeutics USD 68.41M 3.34M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Insmed USD 73.38M 6.53M 2026-03
Ligand Pharmaceuticals USD 37.11M 33.87M 2026-03
Merck USD 3.86B 541M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 14.01M 1.14M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Veracyte USD 6.91M 2.32M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03